Stratos Wealth Partners’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Buy |
14,659
+483
| +3% | +$6.19K | ﹤0.01% | 1348 |
|
|
2025
Q1 | $180K | Buy |
14,176
+971
| +7% | +$12.3K | ﹤0.01% | 1292 |
|
|
2024
Q4 | $173K | Hold |
13,205
| – | – | ﹤0.01% | 1371 |
|
|
2024
Q3 | $199K | Buy |
13,205
+408
| +3% | +$6.15K | ﹤0.01% | 1345 |
|
|
2024
Q2 | $181K | Buy |
12,797
+433
| +4% | +$6.14K | ﹤0.01% | 1280 |
|
|
2024
Q1 | $169K | Buy |
12,364
+614
| +5% | +$8.37K | ﹤0.01% | 1299 |
|
|
2023
Q4 | $158K | Hold |
11,750
| – | – | ﹤0.01% | 1296 |
|
|
2023
Q3 | $147K | Buy |
11,750
+294
| +3% | +$3.67K | ﹤0.01% | 1202 |
|
|
2023
Q2 | $155K | Buy |
11,456
+258
| +2% | +$3.49K | ﹤0.01% | 1118 |
|
|
2023
Q1 | $156K | Sell |
11,198
-9
| -0.1% | -$125 | ﹤0.01% | 1059 |
|
|
2022
Q4 | $159K | Buy |
11,207
+232
| +2% | +$3.3K | ﹤0.01% | 1065 |
|
|
2022
Q3 | $150K | Sell |
10,975
-161
| -1% | -$2.2K | ﹤0.01% | 1051 |
|
|
2022
Q2 | $158K | Buy |
11,136
+673
| +6% | +$9.55K | ﹤0.01% | 1109 |
|
|
2022
Q1 | $173K | Buy |
10,463
+247
| +2% | +$4.08K | ﹤0.01% | 1193 |
|
|
2021
Q4 | $196K | Buy |
10,216
+216
| +2% | +$4.14K | ﹤0.01% | 1179 |
|
|
2021
Q3 | $208K | Buy |
10,000
+196
| +2% | +$4.08K | 0.01% | 1086 |
|
|
2021
Q2 | $210K | Buy |
+9,804
| New | +$210K | 0.01% | 1103 |
|
|
2018
Q4 | – | Sell |
-830
| Closed | -$17K | – | 1559 |
|
|
2018
Q3 | $17K | Buy |
+830
| New | +$17K | ﹤0.01% | 1953 |
|
|
2018
Q2 | – | Sell |
-798
| Closed | -$15K | – | 1684 |
|
|
2018
Q1 | $15K | Buy |
798
+16
| +2% | +$301 | ﹤0.01% | 2129 |
|
|
2017
Q4 | $15K | Buy |
+782
| New | +$15K | ﹤0.01% | 1999 |
|